Skip to content
Traceability · In development

Thalivia Traceability

Software in development for the documentation and traceability of intrathecal pump refills, for pain teams practising intrathecal analgesia. CE marking and availability are planned for the first quarter of 2027. It is not available for clinical use until then.

The problem, as seen by the team

Intrathecal analgesia relies on an implanted pump that must be refilled at regular intervals, often with mixtures of several molecules. Each refill involves several people: the physician who decides its content, the hospital pharmacy that prepares it, and the physician or nurse who performs it.

In many centres, the information needed to follow a patient over the years is scattered between paper forms, spreadsheets and the hospital patient record. It travels from one professional to another at every refill, sometimes across several departments. At the same time, the team must be able to show at any moment what was decided, prepared and performed, by whom and when.

Thalivia Traceability is being developed to give these teams a single, structured place to document this follow-up.

Status. Thalivia Traceability is software in development. CE marking and availability are planned for the first quarter of 2027. It is not available for clinical use until then.

Who it is for

The software is intended for healthcare professionals working in pain teams that practise intrathecal analgesia in healthcare institutions:

  • physicians, including pain specialists and anaesthesiologists;
  • nurses involved in pump refills and patient follow-up;
  • hospital pharmacists.

It is not intended to be used by patients.

What the software does

Thalivia Traceability is designed to record, structure and trace the information entered by healthcare professionals during the follow-up of patients treated with intrathecal analgesia, and to present it back to them in a readable form.

  • An intrathecal follow-up record for each patient. Implantation, implanted pump and successive refills are documented in one place, in chronological order.
  • A time-stamped history of every refill. Each refill is recorded with its date and time and linked to the professional who entered it. The history of earlier refills remains available for consultation.
  • Structured information shared within the team. Physicians, nurses and hospital pharmacists consult the same information, each with access suited to their role.
  • Export of recorded data. The information entered can be exported as documents and spreadsheets, for example for the institution’s own records.

Principles

The physician remains the sole decision-maker. Treatment decisions are made by the physician in charge, using clinical judgement. Thalivia Traceability records and presents the information entered by the team. It does not interpret this information, makes no suggestion and does not propose or adjust any treatment.

No connection to the pump. The software is not connected to the implanted pump, does not control any device and does not monitor patients.

Security and confidentiality. Data are hosted in France by a certified health data host (HDS). Access is limited to authorised professionals, according to their role, with multi-factor authentication. Significant actions are recorded in an audit trail.

Built with practitioners

Thalivia Traceability is designed with pain teams, based on their day-to-day practice. It builds on more than ten years of clinical use of a previous-generation tool in a French cancer centre, with more than 1,000 patients followed. Dr Denis Dupoiron is the scientific advisor of the project.

Availability

Thalivia Traceability is intended for intrathecal analgesia teams in different countries, with a multilingual interface. CE marking and availability are planned for the first quarter of 2027. It is not available for clinical use until then.

Interested teams can contact us.

Thalivia Traceability: your questions

Is Thalivia Traceability a medical device?
Yes. Thalivia Traceability is software intended to be CE marked as a Class I medical device. CE marking is planned for the first quarter of 2027. Until then, it is not available for clinical use.
Does the software take part in treatment decisions?
No. The content of each refill, including doses, is decided by the physician in charge and entered by the team. The software records and presents this information. It does not interpret it, makes no suggestion and does not propose or adjust any treatment.
Where are the data hosted?
Data are hosted in France by a certified health data host (HDS). Access is limited to authorised professionals according to their role, with multi-factor authentication, and significant actions are recorded in an audit trail.
When will it be available?
CE marking and availability are planned for the first quarter of 2027. Interested teams can contact us to be kept informed.
What is the link with Thalivia Community?
They are two separate tools. Thalivia Community is a discussion space between peers and does not host patient records. Thalivia Traceability is intended for documenting the follow-up of the patients of a care team. Members of Thalivia Community are kept informed of the progress of Thalivia Traceability.

Interested in Thalivia Traceability?

Tell us about your team, your country and how you document intrathecal refills today. We will keep you informed of the progress of the software.